Optimi Health (OPTH) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $3.38, +5.96% vs the prior close of $3.19.
- Volume 19.95K shares, 0.5x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
OPTH jumps 6.0% to $3.38. Closed at $3.38, +5.96% vs the prior close of $3.19. Day range $3.19–$3.47, opened at $3.19.
OPTH daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — OPTH jumps 6.0% to $3.38
- Closed at $3.38, +5.96% vs the prior close of $3.19. Day range $3.19–$3.47, opened at $3.19.
- Volume was 19.95K shares, 0.5x its 50-day average of 43.40K — lighter than usual.
- Price is -26.5% vs its 50-day average ($4.60).
- 52-week range $3.04–$6.40; today's close sits at 10% of that range, 47.2% below the 52-week high.
Oct 15, 2026 — OPTH rises 0.6% to $3.19
- Closed at $3.19, +0.63% vs the prior close of $3.17. Day range $3.05–$3.44, opened at $3.24.
- Volume was 34.90K shares, 0.8x its 50-day average of 43.55K.
- Price is -31.2% vs its 50-day average ($4.64).
- 52-week range $3.04–$6.40; today's close sits at 4% of that range, 50.2% below the 52-week high.
Oct 14, 2026 — OPTH slides 9.4% to $3.17, a 3-month low, 4 down days in a row
- Closed at $3.17, -9.43% vs the prior close of $3.50. Day range $3.04–$3.54, opened at $3.54.
- Volume was 54.60K shares, 1.3x its 50-day average of 42.77K.
- Price is -32.2% vs its 50-day average ($4.67).
- 52-week range $3.04–$6.40; today's close sits at 4% of that range, 50.5% below the 52-week high.
- That makes 4 straight losses.
Oct 13, 2026 — OPTH slides 3.6% to $3.50, a 3-month low, 3 down days in a row
- Closed at $3.50, -3.58% vs the prior close of $3.63. Day range $3.31–$3.67, opened at $3.55.
- Volume was 34.60K shares, 0.8x its 50-day average of 42.70K.
- Price is -25.6% vs its 50-day average ($4.70).
- 52-week range $3.30–$6.40; today's close sits at 6% of that range, 45.3% below the 52-week high.
- That makes 3 straight losses.
Oct 12, 2026 — OPTH slides 9.7% to $3.63, a 3-month low
- Closed at $3.63, -9.70% vs the prior close of $4.02. Day range $3.30–$4.03, opened at $4.03.
- Volume was 54.20K shares, 1.3x its 50-day average of 42.19K.
- Price is -23.3% vs its 50-day average ($4.73).
- 52-week range $3.30–$6.40; today's close sits at 11% of that range, 43.3% below the 52-week high.
Oct 9, 2026 — OPTH dips 1.7% to $4.02, a 3-month low
- Closed at $4.02, -1.71% vs the prior close of $4.09. Day range $4.00–$4.20, opened at $4.10.
- Volume was 21.40K shares, 0.5x its 50-day average of 42.22K — lighter than usual.
- Price is -15.5% vs its 50-day average ($4.76).
- 52-week range $4.00–$6.40; today's close sits at 1% of that range, 37.2% below the 52-week high.
Oct 8, 2026 — OPTH rises 1.2% to $4.09
- Closed at $4.09, +1.24% vs the prior close of $4.04. Day range $4.02–$4.19, opened at $4.03.
- Volume was 16.30K shares, 0.4x its 50-day average of 42.23K — lighter than usual.
- Price is -14.2% vs its 50-day average ($4.77).
- 52-week range $4.00–$6.40; today's close sits at 4% of that range, 36.1% below the 52-week high.
Oct 7, 2026 — OPTH dips 2.2% to $4.04, a 3-month low, 7 down days in a row
- Closed at $4.04, -2.18% vs the prior close of $4.13. Day range $4.01–$4.14, opened at $4.14.
- Volume was 17.30K shares, 0.4x its 50-day average of 42.32K — lighter than usual.
- Price is -15.5% vs its 50-day average ($4.78).
- 52-week range $4.00–$6.40; today's close sits at 2% of that range, 36.9% below the 52-week high.
- That makes 7 straight losses.
- SEC filings that day: 6-K.
Oct 6, 2026 — OPTH slides 4.0% to $4.13, a 1-month low, 6 down days in a row
- Closed at $4.13, -3.95% vs the prior close of $4.30. Day range $4.02–$4.24, opened at $4.21.
- Volume was 52.40K shares, 1.3x its 50-day average of 41.53K.
- Price is -13.9% vs its 50-day average ($4.80).
- 52-week range $4.00–$6.40; today's close sits at 5% of that range, 35.5% below the 52-week high.
- That makes 6 straight losses.
Oct 5, 2026 — OPTH slides 4.2% to $4.30, a 1-month low, 5 down days in a row
- Closed at $4.30, -4.23% vs the prior close of $4.49. Day range $4.19–$4.66, opened at $4.61.
- Volume was 29.20K shares, 0.7x its 50-day average of 41.30K.
- Price is -10.6% vs its 50-day average ($4.81).
- 52-week range $4.00–$6.40; today's close sits at 13% of that range, 32.8% below the 52-week high.
- That makes 5 straight losses.
Oct 2, 2026 — OPTH slides 3.2% to $4.49, 4 down days in a row
- Closed at $4.49, -3.23% vs the prior close of $4.64. Day range $4.42–$4.61, opened at $4.58.
- Volume was 13.90K shares, 0.3x its 50-day average of 42.18K — lighter than usual.
- Price is -6.8% vs its 50-day average ($4.82).
- 52-week range $4.00–$6.40; today's close sits at 20% of that range, 29.8% below the 52-week high.
- That makes 4 straight losses.
OPTH latest news & SEC filings
Every SEC filing by or about OPTH in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 7, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 5, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 29, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 23, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 22, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 16, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 10, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 8, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 27, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 27, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 25, 2026 · Form EFFECT — EFFECT filing
EFFECT filing
Aug 17, 2026 · Form F-1 — F-1 filing
F-1 filing
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 14, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 14, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 7, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade OPTH
- How much it moves: over the last 20 sessions the average daily move was 2.92% (largest 9.7%).
- Liquidity: about 34.15K shares (≈$115.42K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $3.38 vs a range of $3.04–$6.40 (10% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Oct 7, 2026; 6-K Sep 29, 2026; 6-K Sep 23, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
OPTH market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 3.19 | 3.47 | 3.19 | 3.38 | 19.95K |
| Oct 15, 2026 | 3.24 | 3.44 | 3.05 | 3.19 | 34.90K |
| Oct 14, 2026 | 3.54 | 3.54 | 3.04 | 3.17 | 54.60K |
| Oct 13, 2026 | 3.55 | 3.67 | 3.31 | 3.50 | 34.60K |
| Oct 12, 2026 | 4.03 | 4.03 | 3.30 | 3.63 | 54.20K |
| Oct 9, 2026 | 4.10 | 4.20 | 4.00 | 4.02 | 21.40K |
| Oct 8, 2026 | 4.03 | 4.19 | 4.02 | 4.09 | 16.30K |
| Oct 7, 2026 | 4.14 | 4.14 | 4.01 | 4.04 | 17.30K |
| Oct 6, 2026 | 4.21 | 4.24 | 4.02 | 4.13 | 52.40K |
| Oct 5, 2026 | 4.61 | 4.66 | 4.19 | 4.30 | 29.20K |
| Oct 2, 2026 | 4.58 | 4.61 | 4.42 | 4.49 | 13.90K |
| Oct 1, 2026 | 4.74 | 4.81 | 4.56 | 4.64 | 30.90K |
| Sep 30, 2026 | 4.87 | 4.95 | 4.69 | 4.71 | 34.80K |
| Sep 29, 2026 | 4.81 | 4.84 | 4.59 | 4.78 | 43.20K |
| Sep 28, 2026 | 4.79 | 5.00 | 4.76 | 4.85 | 15.80K |
| Sep 25, 2026 | 4.85 | 4.99 | 4.78 | 4.82 | 13.20K |
| Sep 24, 2026 | 4.93 | 4.93 | 4.76 | 4.90 | 26.80K |
| Sep 23, 2026 | 4.96 | 5.15 | 4.96 | 4.96 | 52.60K |
| Sep 22, 2026 | 4.85 | 5.10 | 4.85 | 4.96 | 31.00K |
| Sep 21, 2026 | 4.99 | 4.99 | 4.75 | 4.84 | 85.90K |
About Optimi Health
Optimi Health (OPTH) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in VANCOUVER, British Columbia, Canada. State of incorporation: British Columbia, Canada. Fiscal year ends September 30. SEC CIK 2027329.
OPTH board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
OPTH financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
OPTH earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on OPTH
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.